P-glycoprotein expression in osteosarcomas;P-GLYKOPROTEINEXPPRESSION BEIM OSTEOSARKOM

Pathologe

Volumn 17, Issue 1, 1996, Pages 50-55

  Posl M ^b   Grahl, K ^a,b   Amling, M ^a,b   Werner, M ^a,b   Ritzel, H ^a,b   Stenzel, I ^a,b   Hentz, M ^a,b   Winkler, K ^a,b   Delling, G ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b NONE

Author keywords

Chemotherapy; Multidrug resistance; Osteosarcoma; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOSARCOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR BIOPSY; ADJUVANT CHEMOTHERAPY; BONE; BONE TUMOR; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE AND BONES; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG RESISTANCE, MULTIPLE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; P-GLYCOPROTEIN; TREATMENT OUTCOME;

EID: 0029666035     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050134     Document Type: Article

References (34)

1. Borst P, Schinkel AH, Smit JJM, Wagenaar E, van Deetmer L, Smith AJ, Eijdems EWHM, Baas F, Zaman GJR (1993) Classical and novel forms of multidrug resistance and the physiological functions of p-glycoproteins in mammals. Pharmac Ther 60: 289-299
2. Brock I, Hipfner DR, Nielsen BS, Deeley RG, Cole SP, Sehesred M (1995) Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP - 16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res 55: 459-62
3. Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Odrusek N, Yeger H, Ling V (1991) P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325: 1608-1614
4. Chan HSL, Thorner PS, Haddad G, Ling V (1990) Immunohistochemical detection of p-glycoprotein. Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689-704
5. Childs S, Ling V (1994) The mdr superfamily of genes and its biological implications. Import Adv Oncol, pp 21-36
6. Cordell JL, Falini B, Erber WN, Gosh AL, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DJ (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229
7. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in the human normal and tumor tissue. J Histochem Cytochem 38: 1277-1287
8. Delling G (1972) Über eine vereinfachte Methacrylateinbettung für unentkalkte Knochenschnitte. Beitr Pathol 145: 100-102
9. Duesing S, Dallmann I, Grosse J, Buer J, Lopez-Hanninen E, Deckert M, Storkel S. Kirchner H, Poliwoda H, Atzpodien J (1994) Immunocytochemical detection of p-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients. Oncology 51: 309-313
10. Edicott JA, Ling V (1989) The biochemistry of p-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 58: 137-151
11. Fujii H, Tanigawa N, Muraoka R, Shimomatsuya T, Tanaka T (1993) Detection of the p-glycoprotein in solid tumors by flow cytometry. Anticancer Res 13: 2171-2175
12. Gerlach JH, Bell DR, Karakousis C, Slocum HK, Kartnrer N, Rustum YM, Ling V, Baker RM (1987) P-glycoprotein in human sarcoma. Evidence for multidrug resistance. J Clin Oncol 5: 1452-1460
13. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124
14. Itsubo M, Ishikawa T, Toda G, Tanaka M (1994) Immunohistochemical study of the expression and cellular localisation of the multidrug resistance gene product p-glycoprotein in primary liver carcinoma. Cancer 73: 298-303
15. Kandel RA, Campbell S, Noble-Topham S, Bell R Andrulis IL (1995) Correlation of p-glycoprotein detection by immunohistochemistry with mdr-1 mRNA levels in osteosarcoma. Diagn Mol Pathol 4: 59-65
16. Lepelley P, Soenen V, Preudhomme C, Lai JL, Cosson A, Fenaux P (1994) Expression of the multidrug resistance p-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes. Leukemia 8: 998-1104
17. Petrylak DP, Scher HI, Reuter V, O'Brien JP, Cordon-Cardo C (1994) P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder. Ann-Oncol 5: 835-840
18. Ramani P, Dewchand H (1995) Expression of mdr1/p-glycoprotein and p110 in neuroblastoma. J Pathol 175: 13-22
19. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapie for osteogenic sarcoma. Cancer 49: 1221-1230
20. Scheper RJ, Bulte JWM, Brakkee JGP, Quak JJ, van der School E, Balm AJM, Meuer CJLM, Broxterman HJ, Kuiper CM, Lankelma J, Pinedo HM (1988) Monoclonal antibody JSB-1 detects a highly conserved epitope on the p-glycoprotein associated with multi-drug resistance. Int J Cancer 42: 389-394
21. Salzer-Kuntschik M, Brand G, Delling G (1983) Bestimmung des Regressionsgrades nach Chemotherapie bei malignen Tumoren. Pathologe 4: 136-141
22. Serra M, Scotlandi K, Manara MC, Maurici D, Lollini PL, de Giovanni C, Toffoli G, Baldini N (1993) Establishment and charakterization of multidrug-resistant human osteosarcoma cell lines. Anticancer Res 13: 323-330
23. Sinicrope FA, Hart J, Brasitus TA, Michelassi F, Lee J, Safa AR (1994) Relationship of p-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion. DNA ploidy, and disease relapse. Cancer 74: 2908-2917
24. Stein U, Wunderlich V, Haensch W, Schmidt-Peter P (1993) Expression of the mdr1 gene in bone and soft tissue sarcoma of adult patients. Eur J Cancer 29: 1979-1781
25. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738
26. Valverde MA, Diaz M. Sepulveda FV, Gill DR, Hyde SC, Higgins CF (1992) Volume regulated chlorid channels associated with the human multidrug resistance p-glycoprotein. Nature 355: 830-833
27. van der Valk P, van Kalken CK, Kettelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJLM, Pinedo HM, Scheper RJ (1990) Distribution of multidrug resistance associated p-glycoprotein in normal and neoplastic human tissues. Ann Oncol 1: 56-64
28. Vergier B, Cany L, Bonnet F, Robert J, de Mascarel A, Coindre JM (1993) Expression of the MDR1/P-Glycoprotein in human sarcomas. Br J Cancer 68: 1221-1226
29. Weinstein RS. Kuszak JR, Kluskens LF, Coon JS (1990) P-Glycoprotein in pathology: the multidrug resistance gene family in humans. Hum Pathol 21: 34-47
30. Winkler K, Bielack S (1988) Chemotherapy of osteosarcoma. Sem Orthop 3: 48-58
31. Winkler K, Bieling P, Bielack S, Delling G, Dose C, Jürgens H, Kotz R, Ritter J, Salzer-Kuntschick M (1991) Local control and survival from the cooperative osteosarcoma study group studies of the german society of pediatric oncology and the Vienna bone tumor registry. Clin Orthop Rel Res 270: 79-86
32. Wunder JS, Bell RS, Wold L, Andrulis IL (1993) Expression of the multidrug resistance gene in osteosarcoma: a pilot study. J Orthop Res 11: 396-403
33. Yuen AR, Sikic BI (1994) Multidrug resistance in lymphomas. J Clin Oncol 12: 2453-2459
34. Zochbauer S, Gsur A, Brunner R, Kyrie PA, Lechner K, Pirker R (1994) P-glycoprotein expression as an unfavourable prognostic factor in acute myeloid leukemia. Leukemia 8: 974-977